Human Treatments

Indian Army launches first-of-its-kind skin bank for severe burn treatment

The Indian Army has launched a first-of-its-kind skin bank facility that aims to revolutionise the treatment of severe burn injuries and other skin-related conditions for service personnel and their families. The defence ministry in a statement on Tuesday said the skin bank will be staffed by a team of highly-trained medical professionals, including plastic surgeons, tissue engineers and specialised technicians. The Army Hospital (Research and Referral) here announced the opening of the skin bank facility, a first-of-its-kind to be established within the Armed Forces Medical Services, it said. "This landmark initiative aims to revolutionise the treatment of severe burn injuries and other skin-related conditions among service members and their families," the statement said. This bank will serve as a centralised hub for the collection, processing, storage and distribution of skin grafts, providing a "critical resource" for military medical centres across the country, officials said.

Centre plans to introduce cashless treatment of accident victims pan India

The Ministry of Road Transport and Highways (MoRTH) plans to roll out the facility of cashless medical treatment of road accident victims across the country in three to four months, a top government official said on Monday. Road Transport and Highways Secretary Anurag Jain while inaugurating an event organized by the Institute of Road Traffic Education (IRTE) noted India has the highest number of road accident deaths in the world. "Free and cashless medical treatment to accident-injured victims is part of the amended Motor Vehicle Act 2019 (MVA2019). Some states have implemented it but now the Ministry of Roads in league with the Ministry of Health and Family Welfare will be fully implementing it across the nation," Jain said. He added the facility will be rolled out in three to four months. According to him, it is envisioned to provide access to cashless trauma care treatment for road accident victims at the nearest appropriate hospital in the country, in accordance with the Supre

Santaan deploys cutting edge AI for better outcomes in fertility treatments

.

Study opens way for new treatments by finding how Covid damages heart

Researchers have discovered how COVID-19 infection damages the heart tissue, paving the way for better treatments for the condition. The study conducted on a small group of people found that COVID-19 damaged the DNA in heart tissue, which was not detected in influenza samples. The researchers noted that while COVID-19 and influenza are both severe respiratory viruses, they appeared to affect cardiac tissue very differently. "In comparison to the 2009 flu pandemic, COVID has led to more severe and long-term cardiovascular disease but what was causing that at a molecular level was not known," said Arutha Kulasinghe from the University of Queensland, Australia. "During our study, we couldn't detect viral particles in the cardiac tissues of COVID-19 patients, but what we found was tissue changes associated with DNA damage and repair," Kulasinghe said. DNA damage and repair mechanisms are related to chronic diseases such as diabetes, cancer, atherosclerosis and neurodegenerative disord

60% people delay treatment due to lack of health cover, reveals survey

Around 60 per cent respondents have been delaying treatment due to lack of health cover and 67 per cent who have medical insurance find it difficult to understand, a study by Pristyn Care Data Labs said on Wednesday. According to the study conducted during August 1-25, 2022 by the startup firm, a vast majority of people want alternative treatments such as ayurveda, unani, siddha, homeopathy and naturopathy to be covered under health insurance. "India has the lowest rates of health insurance penetration and COVID-19 induced medical inflation has caused people to delay surgeries. Elective surgeries are not life-threatening but any delay can impact the overall quality of life," Pristyn Care co-founder Harsimarbir Singh said in a statement. With the rising costs of medical treatments in the country, as per the study, nearly 60 per cent of the respondents are delaying treatment due to the lack of any health cover. The survey based on inputs received from over 1,100 people and internal d

Covid treatments for better protection against future variants identified

Researchers have identified new therapies for COVID-19 that they say could provide better protection against future variants and outbreaks. An international team led by researchers from the University of Kent in the UK and the Goethe-University in Germany tested the sensitivity of different SARS-CoV-2 Omicron and Delta viruses to combinations of the four currently approved antiviral drugs with betaferon. Betaferon is a class of antiviral drug that is also naturally produced in the body and protect it from virus infections. The recent COVID-19 waves have caused fewer hospitalisations and deaths than the initial ones -- largely due to the immunity provided by vaccines, the researchers said. However, many people have defects in their immune systems and cannot effectively protect themselves from COVID-19 by vaccination and rely on effective antiviral therapies, they said. The researchers noted that threat of resistance formation for antiviral drugs, which can happen quickly and cause

Lack of treatment guidelines hampering monkeypox care globally, study shows

A dearth of high quality, up to date clinical guidance on monkeypox may be hampering effective and safe treatment of the infection around the world, according to a review

Tomato fever: India reports another viral disease after Covid-19, monkeypox

What is tomato fever? Here are the causes, symptoms, treatment and other details of the disease

Glenmark acquires Wockhardt's key OTC brands in US for undisclosed sum

Deal includes approved ANDAs for famotidine tablets, used in treatment and prevention of ulcers stomach and intestinal ulcers

Biocon partners Adagio for licence to make Covid-19 antibody cocktail

Treatment claims to address the resistant Delta variant as well

Biocon Biologics gets licence from Adagio for antibody Covid treatment

Initial data indicate that ADG20 could provide both rapid and durable protection against Covid-19 for up to one year

Insurance claims related to coronavirus treatment rise in September

Overall, coronavirus cases have been on the rise, especially in few states. The recovery rate is also high

Health Ministry adds steroid dexamethasone in Covid-19 treatment protocol

It also recommended hydroxychloroquine in patients during the early course of the disease and not on critically ill patients

Gilead's Covid-19 cure trial may yield results ahead of schedule: Report

In the absence of hard evidence, US medical associations and the National Institutes of Health have not recommended remdesivir for treatment of Covid-19 so far

Coronavirus impact: Private insurers bat for standard treatment rates

So far, the number of claims handled by the private insurers from Covid-19 patients has been fairly less. Insurers said related claims have just started trickling in

Cat stem cell trial could lead to human treatments

A trip to the vet confirmed that Smokey had feline chronic gingivostomatitis or FCGS, a painful inflammatory mouth disease